학술논문

The influence of biological and technical factors on quantitative analysis of amyloid PET: Points to consider and recommendations for controlling variability in longitudinal data
Document Type
article
Source
Alzheimer's & Dementia. 11(9)
Subject
Biomedical and Clinical Sciences
Clinical Sciences
Aging
Bioengineering
Alzheimer's Disease
Dementia
Acquired Cognitive Impairment
Neurodegenerative
Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD)
Brain Disorders
Neurosciences
Biomedical Imaging
Amyloid
Brain
Humans
Positron-Emission Tomography
Radiopharmaceuticals
Alzheimer's Disease Neuroimaging Initiative
ADNI
Alzheimer's disease
Multi-site trials
Positron emission tomography
Quantitative analysis
Within subject variability
Geriatrics
Clinical sciences
Biological psychology
Language
Abstract
In vivo imaging of amyloid burden with positron emission tomography (PET) provides a means for studying the pathophysiology of Alzheimer's and related diseases. Measurement of subtle changes in amyloid burden requires quantitative analysis of image data. Reliable quantitative analysis of amyloid PET scans acquired at multiple sites and over time requires rigorous standardization of acquisition protocols, subject management, tracer administration, image quality control, and image processing and analysis methods. We review critical points in the acquisition and analysis of amyloid PET, identify ways in which technical factors can contribute to measurement variability, and suggest methods for mitigating these sources of noise. Improved quantitative accuracy could reduce the sample size necessary to detect intervention effects when amyloid PET is used as a treatment end point and allow more reliable interpretation of change in amyloid burden and its relationship to clinical course.